Conference abstractPublished 25 Jul 2016
NAFLD Biomarker development and progression in psoriasis patients with metabolic syndrome
The Ivano-Frankivsk National Medical University, Ukraine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome (MS) and comprises a disease spectrum ranging from steatosis through nonalcoholic steatohepatitis (NASH) to fibrosis and liver cirrhosis. Psoriasis is a chronic inflammatory skin disease, which commonly associated with MS or its components. The aim of this study was to investigate the NAFLD biomarker development and progression in psoriasis patients with MS
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDermatology
- SubjectDiabetes & Endocrinology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Nataliya Virstyuk”